Electrochemical reduction mechanism of camptothecin at glassy carbon electrode

Bioelectrochemistry

Volumn 79, Issue 2, 2010, Pages 173-178

  Shah, Afzal ^a,b   Diculescu, Victor C ^a   Qureshi, Rumana ^b   Oliveira Brett, Ana Maria ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b QUAID I AZAM UNIVERSITY   (Pakistan)

Author keywords

Adsorption; Camptothecin (CPT); Lactone ring; Reduction; Voltammetry

Indexed keywords

ACETATE BUFFERS; ACID MEDIA; CAMPTOTHECINS; CHARGE-TRANSFER REACTIONS; CYTOTOXIC; DIFFERENTIAL PULSE; DIFFERENTIAL PULSE VOLTAMMETRY; DIFFUSION COEFFICIENTS; ELECTROCHEMICAL REDUCTIONS; GLASSY CARBON ELECTRODES; LACTONE RING; LACTONE RINGS; NUMBER OF ELECTRONS; PH-DEPENDENT; QUASI-REVERSIBILITY; REDUCTION MECHANISMS; REDUCTION PEAK; SQUARE WAVE VOLTAMMETRY; SUPPORTING ELECTROLYTE; TOPOISOMERASE I; WIDE PH RANGE;

ADSORPTION; BODY FLUIDS; CHARGE TRANSFER; ELECTRODES; ELECTROLYTES; ELECTROLYTIC REDUCTION; ENZYME INHIBITION; GLASS MEMBRANE ELECTRODES; GLASSY CARBON; ION EXCHANGE; PROTONS;

CYCLIC VOLTAMMETRY;

ACETIC ACID; CAMPTOTHECIN; CARBON; ELECTROLYTE; LACTONE;

ADSORPTION; ARTICLE; CALCULATION; CYCLIC POTENTIOMETRY; DIFFERENTIAL PULSE VOLTAMMETRY; DRUG STRUCTURE; ELECTROCHEMICAL ANALYSIS; ELECTRODE; ELECTRON; HYDROXYLATION; MEASUREMENT; PROTON TRANSPORT; REDUCTION;

CAMPTOTHECIN; CARBON; ELECTROCHEMISTRY; ELECTRODES; GLASS; HYDROGEN-ION CONCENTRATION; HYDROXYLATION; LACTONES; OXIDATION-REDUCTION; TOPOISOMERASE I INHIBITORS;

EID: 77955276847     PISSN: 15675394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bioelechem.2010.03.001     Document Type: Article

References (29)

1. Wang X., Zhou X., Hecht S.M. Role of the 20-hydroxyl group in camptothecin binding by the topoisomerase I-DNA binary complex. Biochem. 1999, 38:4374-4381.
2. Bendixen C., Thomsen B., Alsner J., Westergaard O. Camptothecin-stabilized topoisomerase I-DNA adducts cause premature termination of transcription. Biochem. 1990, 29:5613-5619.
3. Bodley A., Cumming J., Shapiro T. Effects of camptothecin, a topoisomerase I inhibitor, on Plasmodium falciparum. Biochem. Pharmacol. 1998, 55:709-711.
4. Berman J.D. Human leishmaniasis: clinical, diagnostic and chemotherapeutic developments in the last 10years. Clin. Infect. Dis. 1997, 24:684-703.
5. Bodley A., Wani M., Wall M., Shapiro T. Antitrypanosomal activity of camptothecin analogs: structure-activity correlations. Biochem. Pharmacol. 1995, 50:937-942.
6. Priel E., Showalter S.D., Blair D.G. Inhibition of human immunodeficiency virus (HIV-I) replication by non cytotoxic. doses of camptothecin, a topoisomerase I inhibitor. AIDS Res. Hum. Retrov. 1991, 7:65-72.
7. Carbonero R.G., Supko J.G. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins. Clin. Cancer Res. 2002, 8:641-661.
8. Dora C.L., Silva M.A., Trentin A.G., Faria T.J., Fernandes D., Costa R.D., Stimamiglio M., Senna E.L. Evaluation of antimetastatic activity and systemic toxicity of camptothecin-loaded microspheres in mice injected with B16-F10 melanoma cells. J. Pharm. Pharmaceut. Sci. 2006, 9:22-31.
9. Takimoto C.H., Wright J., Arbuck S.G. Clinical applications of the camptothecins. Biochim. Biophys. Acta 1998, 1400:107-119.
10. O'Leary J., Muggia F.M. Camptothecins: a review of their development and schedules of administration. Eur. J. Cancer 1998, 34:1500-1508.
11. Hecht S.M. Camptothecin: roles of the D and E rings in binding to the topoisomerase I-DNA covalent binary complex. Curr. Med. Chem. Anti Cancer Agents 2005, 5:353-362.
12. Xiao X.S., Cushman M. Effect of E-ring modifications in camptothecin on topoisomerase I. Inhibition: a quantum mechanics treatment. J. Org. Chem. 2005, 70:9584-9587.
13. Dvoranová D., Brezová V., Valko M., Stasko A. Photoinduced transformation of camptothecin in the presence of iron(III) ions. J. Photochem. Photobio. A. Chem. 2007, 185:172-180.
14. Li M., Tang W., Zeng F., Lou L., You T. Semi-synthesis and biological activity of c-lactones analogs of camptothecin. Bioorg. Med. Chem. Lett. 2008, 18:6441-6443.
15. Hertzberg R.P., Caranfa M.J., Holden K.G., Jakas D.R., Gallagher G., Mattern M.R., Mong S.M., Bartus J.O., Johnson R.K., Kingsbury W.D. Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity. J. Med. Chem. 1989, 32:715-720.
16. Fan Y., Weinstein J.N., Kohn K.W., Shi L.M., Pommier Y. Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin. J. Med. Chem. 1998, 41:2216-2226.
17. Staker B.L., Hjerrild K., Feese M.D., Behnke C.A., Burgin A.B., Stewart L. The mechanism of topoisomerase I poisoning by a camptothecin analog. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:15387-15392.
18. Fassberg J., Stella V.J. A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. J. Pharm. Sci. 1992, 81:676-684.
19. Burke T.G., Mi Z.H. Preferential binding of the carboxylate form of camptothecin by human serum albumin. Anal. Biochem. 1993, 212:285-287.
20. Fassberg J., Stella V.J. A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. J. Pharm. Sci. 1992, 81:676-684.
21. Posokhov Y., Biner H., Icli S. Spectral-luminescent and solvatochromic properties of anticancer drug camptothecin. J. Photochem. Photobiol. A: Chem. 2003, 158:13-20.
22. Dey J., Warner I.M. Spectroscopic and photophysical studies of the anticancer drug: camptothecin. J. Lumin. 1997, 71:105-114.
23. Dey J., Warner I.M. Excited state tautomerization of camptothecin in aqueous solution. J. Photochem. Photobiol. A: Chem. 1996, 101:21-27.
24. Zhao H., Lee C., Sai P., Choe Y.H., Boro M., Pendri A., Guan S., Greenwald R.B. 20-O-acylcamptothecin derivatives: evidence for lactone stabilization. J. Org. Chem. 2000, 65:4601-4606.
25. Zhao J., Zheng X., Xing W., Huang J., Li G. Electrochemical studies of camptothecin and its interaction with human serum albumin. Int. J. Mol. Sci. 2007, 8:42-50.
26. Ahmed F., Vyasa V., Saleem A., Li X.G., Zamek R., Cornfield A., Haluska P., Ibrahim N., Rubin E.H., Gupta E. High-performance liquid chromatographic quantitation of total and lactone 20(S)camptothecin in patients receiving oral 20(S)camptothecin. J. Chromatogr. B 1998, 707:227-233.
27. Brett C.M.A., Oliveira-Brett A.M. Electrochemistry. Principles, Methods and Applications 1993, Oxford University Press, UK.
28. Diculescu V.C., Enache T.A., Oliveira P.J., Oliveira-Brett A.M. Electrochemical oxidation of berberine and of its oxidation products at a glassy carbon electrode. Electroanal. 2009, 21:1027-1034.
29. Du W. Towards new anticancer drugs: a decade of advances in synthesis of camptothecins and related alkaloids. Tetrahedron 2003, 59:8649-8687.